| ‘In silico’oncology for clinical decision making in the context of nephroblastoma N Graf, A Hoppe, E Georgiadi, R Belleman, C Desmedt, D Dionysiou, ... Klinische Paediatrie 221 (03), 141-149, 2009 | 36 | 2009 |
| ▪ In Silico Oncology: Part II—Clinical Requirements Regarding In Silico Oncology N GRAF Multiscale Cancer Modeling, 462-471, 2010 | 4 | 2010 |
| 0613/# 917 Characteristics and Outcome of Pediatric Patients With Renal Cell Carcinoma Registered in International Society of Pediatric Oncology Renal Tumor Study Group 93-01 … JN Van der Beek, JA Hol, A Coulomb-L'Hermine, N Graf, H Van Tinteren, ... Pediatric Blood & Cancer 67 (s4), S276-S277, 2020 | | 2020 |
| 12 Der Einfluss des virtuellen Patienten auf das Design von klinischen Studien R David, Y Braun, H Stenzhorn, N Graf | | |
| 12q13, a new recurrent breakpoint in acute non-lymphoblastic leukemia MMB Seyger, J Ritterbach, U Creutzig, AK Gnekow, U Göbel, N Graf, ... Cancer genetics and cytogenetics 80 (1), 23-28, 1995 | 11 | 1995 |
| 1q gain is a frequent finding in preoperatively treated Wilms tumors, but of limited prognostic value for risk stratification in the SIOP2001/GPOH trial. C Vokuhl, W Vogelgesang, I Leuschner, R Furtwängler, N Graf, M Gessler, ... Genes, Chromosomes & Cancer 53 (11), 960-962, 2014 | 5 | 2014 |
| 25 years of ESPED as a surveillance tool for rare diseases in children in Germany: a critical analysis D Ebrahimi-Fakhari, M Zemlin, H Sauer, M Poryo, N Graf, S Meyer Klinische Padiatrie 230 (4), 215-224, 2018 | 13 | 2018 |
| 256 Integrated analysis of DNA methylation, copy number and expression data in Wilms Tumour identifies subtype-specific molecular signatures J Charlton, M Alcaide-German, T Chagtai, S Popov, N Sebire, M Gessler, ... European Journal of Cancer 3 (51), S45, 2015 | | 2015 |
| 282Nephroblastoma: Role of radiotherapy within the frame of the SIOP/GPOH experience R Pötter, M Flentje, G Tatzreiter, A Weirich, N Graf, R Ludwig Radiotherapy and Oncology, S74, 1996 | | 1996 |
| 3× 14 mg/m2 idarubicin during induction: results of a pilot study in children with AML U Creutzig, D Körholz, CM Niemeyer, K Kabisch, N Graf, A Reiter, ... Leukemia 14 (2), 340-342, 2000 | 9 | 2000 |
| 398 POSTER Clinical requirements of “In Silico Oncology” as part of the integrated project ACGT (Advancing Clinico-Genomic Trials on Cancer) N Graf, C Desmedt, A Hoppe, M Tsiknakis, D Dionysiou, G Stamatakos EJC Supplements 4 (5), 83, 2007 | 3 | 2007 |
| 3D Strain Echokardiografie zur Beurteilung der myokardialen Funktion bei Patienten mit Anthrazyklintherapie E Steuer, A Rentzsch, A Dite, T Rädle-Hurst, T Krenn, N Graf, ... The Thoracic and Cardiovascular Surgeon 64 (S 02), ePP52, 2016 | | 2016 |
| 3D-Formanalyse von retroperitonealen Tumoren im Kindesalter: Entwicklung einer statistischen 2D/3D-Methodik und Anwendung dieser mit MRT-Datensätzen SM Giebel, J Schiltz, N Nourkami, N Graf, JP Schenk RöFo-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden …, 2010 | 1 | 2010 |
| 3D-visualization by MRI for surgical planning of Wilms tumors JP Schenk, KL Waag, N Graf, R Wunsch, C Jourdan, W Behnisch, ... RoFo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der …, 2004 | 26* | 2004 |
| 3D-visualization by MRI for surgical planning of Wilms tumors; 3-D-Visualisierung in der MRT zur Operationsplanung von Wilms-Tumoren JP Schenk, R Wunsch, C Jourdan, J Troeger, KL Waag, P Guenther, ... RoeFo-Fortschritte auf dem Gebiete der Roentgenstrahlen und der Neuen …, 2004 | | 2004 |
| 4103 ORAL Doxorubicin Can Be Safely Omitted From the Treatment of Stage ll/lll, Intermediate Risk Histology Wilms Tumour–Results of the SIOP WT 2001 Randomised Trial, on Behalf … K Pritchard-Jones, N Graf, C Bergeron, B de Camargo, M van den Heuvel, ... European Journal of Cancer, S284-S285, 2011 | | 2011 |
| 566: Comparative Genomic Hybridization of Chemotherapy Survived Wilms' Tumor Cells T Schlomm, B Gunawan, HJ Schulten, N Graf, I Leuschner, RH Ringert, ... The Journal of Urology 171 (4S), 150-151, 2004 | | 2004 |
| 721 Comparative genomic hybridization of chemotherapy survived wilms' tumour cells T Schlomm, B Gunawan, HJ Schulten, N Graf, I Leuschner, RH Ringert, ... European Urology Supplements 2 (3), 183, 2004 | | 2004 |
| A Clinical Perspective of Bilateral Renal Tumors-Data from Three Consecutive German Cooperative Trials M Stehr, R Furtwängler, M Schmolze, I Leuschner, D Von Schweinitz, ... Journal of Pediatric Urology 4, S64, 2008 | 1 | 2008 |
| A decision support system for integrated river basin management of the German Elbe J Berlekamp, S Lautenbach, N Graf, M Matthies MODSIM05-International Congress on Modelling and Simulation: Advances and …, 2005 | 9 | 2005 |
Harm van TinterenHoofd afdeling Biometrics, Antoni van Leeuwenhoek在 nki.nl 的电子邮件经过验证
